Largest biotech companies in the United States by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 20 biotech companies in the United States ranked by total liabilities, at ZAR 1.43T, ahead of Gilead Sciences (ZAR 635.2B) and Biogen (ZAR 195.1B). Figures as of 20 Nov 2026, 11:36 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- AmgenZAR 1.43T
- Median
- ZAR 10.1B
- Combined market value
- ZAR 12.82T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | ZAR 1.43T | ZAR 4.14T | ZAR 7,656.97 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | ZAR 635.2B | ZAR 3.6T | ZAR 2,905.78 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | ZAR 195.1B | ZAR 637.4B | ZAR 4,312.17 | 1.70% down | 49% up | ||
| 4 | ModernaMRNA · Health Care | ZAR 64.4B | ZAR 1.41T | ZAR 3,478.11 | 1.29% up | 780% up | ||
| 5 | Halozyme TherapeuticsHALO · Health Care | ZAR 43.2B | ZAR 185.1B | ZAR 1,623.45 | 2.88% down | 39% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | ZAR 24.1B | ZAR 276.6B | ZAR 2,732.34 | 3.85% down | 17% up | ||
| 7 | ImmunityBioIBRX · Health Care | ZAR 17.5B | ZAR 122B | ZAR 114.64 | 1.94% down | 232% up | ||
| 8 | RepligenRGEN · Health Care | ZAR 14.7B | ZAR 189.9B | ZAR 2,971.39 | 1.38% down | 12% up | ||
| 9 | Revolution MedicinesRVMD · Health Care | ZAR 12.6B | ZAR 601.7B | ZAR 2,781.89 | 0.24% down | 129% up | ||
| 10 | ExelixisEXEL · Health Care | ZAR 11.9B | ZAR 280.3B | ZAR 1,148.67 | 3.60% down | 63% up | ||
| 11 | Bio-TechneTECH · Health Care | ZAR 8.3B | ZAR 199.3B | ZAR 1,268.54 | 0.07% down | 18% up | ||
| 12 | VaxcytePCVX · Health Care | ZAR 5.5B | ZAR 161.2B | ZAR 1,018.32 | 0.27% down | 23% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | ZAR 5B | ZAR 79.2B | ZAR 489.44 | 1.44% down | 74% up | ||
| 14 | Kodiak SciencesKOD · Health Care | ZAR 3.4B | ZAR 111.7B | ZAR 1,708.26 | 0.09% up | 399% up | ||
| 15 | Twist BioscienceTWST · Health Care | ZAR 2.9B | ZAR 132.8B | ZAR 1,947.66 | 4.07% down | 291% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | ZAR 2.8B | ZAR 177.8B | ZAR 2,083.24 | 1.44% down | 87% up | ||
| 17 | Scholar Rock HoldingSRRK · Health Care | ZAR 2.8B | ZAR 107.2B | ZAR 878.91 | 4.94% up | 26% up | ||
| 18 | Krystal BiotechKRYS · Health Care | ZAR 2B | ZAR 163.3B | ZAR 5,510.74 | 0.15% up | 54% up | ||
| 19 | ImmunovantIMVT · Health Care | ZAR 1.8B | ZAR 117.4B | ZAR 567.44 | 1.96% down | 46% up | ||
| 20 | CG OncologyCGON · Health Care | ZAR 680.3M | ZAR 127.6B | ZAR 1,429.07 | 2.38% up | 97% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4490 ZAR).
Questions and answers
Which biotech companies in the United States rank first by total liabilities?
Amgen (ZAR 1.43T), Gilead Sciences (ZAR 635.2B) and Biogen (ZAR 195.1B) are the top three of the 20 biotech companies in the United States ranked by total liabilities as of 20 Nov 2026, 11:36 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by total liabilities.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by total liabilities have a combined market value of ZAR 12.82T as of 20 Nov 2026, 11:36 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.